SAFE Act

2/28/2025, 3:53 AM
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill 119 HR 830, also known as the Fentanyl Analogues Control Act, aims to amend the Controlled Substances Act in order to address the growing issue of fentanyl-related substances. Fentanyl is a powerful synthetic opioid that is responsible for a significant portion of overdose deaths in the United States.

The bill seeks to classify fentanyl analogues, which are substances that are chemically similar to fentanyl but have slight variations in their molecular structure, as Schedule I controlled substances. This classification would make it illegal to manufacture, distribute, or possess these substances without proper authorization.

The purpose of this legislation is to combat the spread of fentanyl analogues, which are often created in clandestine laboratories and sold on the black market. These substances are extremely potent and can be even more dangerous than fentanyl itself, leading to a higher risk of overdose and death. By classifying fentanyl analogues as Schedule I controlled substances, law enforcement agencies will have more tools to crack down on the production and distribution of these dangerous substances. This bill is part of a larger effort to address the opioid crisis in the United States and prevent further loss of life due to fentanyl-related overdoses. Overall, the Fentanyl Analogues Control Act is a crucial piece of legislation that aims to protect public health and safety by addressing the proliferation of fentanyl analogues in the illicit drug market.
Congress
119

Number
HR - 830

Introduced on
2025-01-31

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

1/31/2025

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill 119 HR 830, also known as the Fentanyl Analogues Control Act, aims to amend the Controlled Substances Act in order to address the growing issue of fentanyl-related substances. Fentanyl is a powerful synthetic opioid that is responsible for a significant portion of overdose deaths in the United States.

The bill seeks to classify fentanyl analogues, which are substances that are chemically similar to fentanyl but have slight variations in their molecular structure, as Schedule I controlled substances. This classification would make it illegal to manufacture, distribute, or possess these substances without proper authorization.

The purpose of this legislation is to combat the spread of fentanyl analogues, which are often created in clandestine laboratories and sold on the black market. These substances are extremely potent and can be even more dangerous than fentanyl itself, leading to a higher risk of overdose and death. By classifying fentanyl analogues as Schedule I controlled substances, law enforcement agencies will have more tools to crack down on the production and distribution of these dangerous substances. This bill is part of a larger effort to address the opioid crisis in the United States and prevent further loss of life due to fentanyl-related overdoses. Overall, the Fentanyl Analogues Control Act is a crucial piece of legislation that aims to protect public health and safety by addressing the proliferation of fentanyl analogues in the illicit drug market.
Alternative Names
Official Title as IntroducedTo amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes.

Comments

Recent Activity

Latest Action1/31/2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the c...